Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials

Abstract

We performed a meta-analysis to synthesize evidence on the efficacy and safety of physical exercise as an add-on therapeutic intervention for quality of life (QoL), depressive symptoms and cognition across six chronic brain disorders: Alzheimer’s disease, Huntington’s disease, multiple sclerosis, Parkinson’s disease, schizophrenia and unipolar depression. 122 studies ( =  k) ( n = 7231) were included. Exercise was superior to treatment as usual in improving QoL ( k = 64, n = 4334, ES = 0.40, p < 0.0001), depressive symptoms ( k = 60, n = 2909, ES = 0.78, p < 0.0001), the cognitive domains attention and working memory ( k = 21, n = 1313, ES = 0.24, p < 0.009), executive functioning ( k = 14, n = 977, ES = 0.15, p = 0.013), memory ( k = 12, n = 994, ES = 0.12, p = 0.038) and psychomotor speed ( k = 16, n = 896, ES = 0.23, p = 0.003). Meta-regression showed a dose–response effect for exercise time (min/week) on depressive symptoms ( β = 0.007, p = 0.012). 69% of the studies that reported on safety, found no complications. Exercise is an efficacious and safe add-on therapeutic intervention showing a medium-sized effect on QoL and a large effect on mood in patients with chronic brain disorders, with a positive dose–response correlation. Exercise also improved several cognitive domains with small but significant effects.

Electronic supplementary material

The online version of this article (10.1007/s00415-019-09493-9) contains supplementary material, which is available to authorized users.